uniQure Announces Presentations at Upcoming February Conferences
February 06 2017 - 7:00AM
uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today
announced presentations at the following conferences taking place
in February:
Leerink Partners 6th Annual Global
Healthcare Conference, at the Lotte New York Palace Hotel in New
York City
- Matthew Kapusta, chief executive officer, will participate in a
Fireside Chat on Wednesday, February 15th at 3.00 p.m. EST. The
live webcast can be accessed by the link displayed in the Investor
section of the uniQure website at:
http://uniqure.com/investors-newsroom/overview.php. The webcast
replay will be available for at least 72 hours following the live
event.
61st Annual Meeting
of Society of Thrombosis and Hemostatis
Research at the Congress Center in Basel, Switzerland
- Professor Wolfgang Miesbach, M.D. professor of hematology at
the University of Frankfurt, Germany and an investigator in the
ongoing Phase 1-2 clinical trial of AMT-060 (AAV5 hFIX) gene
transfer in adult patients with severe hemophilia B, will present
previously disclosed interim results from the dose escalating study
on Thursday, February 16th at 15.00 CET/ 09.00 a.m. EST.
About uniQure uniQure is
delivering on the promise of gene therapy – single treatments with
potentially curative results. We are leveraging our modular and
validated technology platform to rapidly advance a pipeline of
proprietary and partnered gene therapies to treat patients with
hemophilia, Huntington’s disease and cardiovascular diseases.
www.uniQure.com
uniQure Contacts:
Maria E. Cantor
Direct: 339-970-7536
Mobile: 617-680-9452
m.cantor@uniQure.com
Tom Malone
Direct: 339-970-7558
Mobile: 339-223-8541
t.malone@uniQure.com
Eva M. Mulder
Direct: +31 20 240 6103
Mobile: +31 6 52 33 15 79
e.mulder@uniQure.com
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jun 2024 to Jul 2024
uniQure NV (NASDAQ:QURE)
Historical Stock Chart
From Jul 2023 to Jul 2024